MSCM
NBIX icon

McElhenny Sheffield Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

McElhenny Sheffield Capital Management’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13
Closed -$1.55K – 419
2022
Q4 		$1.55K Buy
+13
New +$1.55K ﹤0.01% 521